[1]
G. Li, M. Heber, and T. Pike-Lee, “An updated review on the utility of hematopoietic stem cell transplant in the treatment of refractory myasthenia gravis”, rrnmf, vol. 6, no. 1, Mar. 2025, doi: 10.17161/rrnmf.v6i1.22987.